GLP3-R 30 mg (retatrutide) research material

Buy Retatrutide 30 mg for laboratory research, listed in this catalog as GLP3-R. It is supplied as lyophilized powder in one boxed 3 mL vial. The original laboratory report links the catalog label to the scientific name.

Compare the available vial sizes

Other presentations in this family are GLP3-R 5 mg, GLP3-R 10 mg, GLP3-R 20 mg. These options change the labeled quantity; choose the amount required for the planned laboratory work and check the records attached to the selected presentation.

This family is distinct from GLP1-S and GLP2-T. Their catalog numbers are names, not a ranking of potency or a basis for substituting equal milligram amounts in an experiment.

Three receptor systems, one defined analog

In Coskun and colleagues’ LY3437943 discovery study, retatrutide showed activity at glucagon, GIP and GLP-1 receptors in vitro. The measured responses differed between receptor systems. “Triple agonist” describes one peptide’s target profile, not three ingredients mixed in a vial.

The published findings concern the authors’ study material and experimental conditions. They provide research context, not certification of this commercial lot, instructions for use or evidence of clinical equivalence.

When comparing a method with the supplied material, check the specified chemical form and modifications. Receptor activity, chromatographic purity and vial content answer separate questions.

Batch documentation and handling

Open COA & Documents and match the product and lot. Read the methods and reported identity, purity and measured content separately. A name or reference formula does not establish an unreported counterion or complete formulation.

The 30 mg value is the labeled amount of material; the 3 mL value is container capacity. Neither specifies a liquid concentration. Use applicable product records and laboratory procedures for storage and preparation.